Hospitals scramble for last of federal Covid money; FDA panel weighs ALS drug

Hospitals, including some flush with cash, are using their muscle in Washington to catch whatever is left from a nearly depleted Covid relief fund.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Hospitals, including some flush with cash, scramble to grab last scraps of federal Covid dollars By Bob Herman Adobe Hospitals are using their muscle in Washington to catch whatever dollars are left from a nearly depleted Covid relief fund. Read More STAT+: Tracking the FDA advisory panel on Amylyx Pharma's ALS treatment By Adam Feuerstein and Nicholas Florko Sarah Silbiger/Getty Images Tune in for updates from a meeting where FDA advisers are reviewing data on the drug and will recommend whether or not it should be approved. Read More Obesity can turn a helpful immunotherapy into a harmful one, mouse study shows By Jonathan Wosen Adobe These early-stage results aren't cause for alarm among people concerned about whether their medications are working, one author cautioned. Read More Sponsor content by STAT Events Last Chance: The STAT Breakthrough Science Summit This Thursday, leaders from Pfizer, Bristol Myers Squibb, and Merck will take the stage to discuss what’s next for their organizations. We’ll also explore the future of CRISPR and unpack the feasibility of pig-to-human transplants. There’s so much more, so check out statnews.com/summit to see the full agenda and find more information about our featured speakers. Then, get your ticket to join us! Opinion: There's no return to normal for millions of children orphaned during Covid By Seth Flaxman and Susan Hillis GAGAN NAYAR/AFP via Getty Images For the millions of children who have become orphans due to Covid-19, their post-pandemic lives will be anything but normal. Read More STAT+: CVS, Teva, and Allergan reach deal with Florida over the opioid crisis By Ed Silverman ERIC BARADAT/AFP via Getty Images The agreement between Florida and CVS, Teva, and Allergan is the latest in a growing number of settlements over the opioid crisis. Read More STAT+: Pharma partnerships with digital therapeutics players to watch  By Mario Aguilar INA FASSBENDER/AFP via Getty Images Pharma companies have struck a string of new deals with digital health startups. Here's STAT's guide to the partnerships to watch. Read More Opinion: Listen: Tom Sequist on mirrored Covid tragedies — 2,000 miles apart By Patrick Skerrett This week on "The First Opinion Podcast," hospital executive Tom Sequist talks about Indigenous health disparities and Covid's deadly nature. Read More Wednesday, March 30, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser